Looking at the Kevetrin study that will start next
Post# of 72440
First, I remember that they were initially doing a combo trial with another medication but it doesn't look like it anymore so this will be Kevetrin against Platinum Resistant cancer which is to me a big sign of confidence by Dr. Mennon.
Second, the outcomes will be measured within days and in some cases just 3 weeks. This means unlike the first Kevetrin study, CTIX and the investigators will know in March how we're doing!